F1D8N1 (F1D8N1_HUMAN) Homo sapiens (Human)

Liver X nuclear receptor alpha variant 1 UniProtKBInterProInteractive Modelling

447 aa; Sequence (Fasta) ; 4 identical sequences: Homo sapiens: Q13133; Pan troglodytes: K7AUZ1, A0A6D2XX46; Pan paniscus: A0A2R9BV37

Available Structures

7 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 32b
5avl
 Heteromer
Q13133; Q15788; 		204-447
2×4KQ;
Assess
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4
5avi
 Heteromer
Q13133; Q15788; 		204-446
2×4KM;
Assess
Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease
5hjs
 Heteromer
Q13133; Q15788; 		205-446
2×668; 2×SO4;
Assess
X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha
3ips
 Heteromer
Q13133; Q15788; 		205-446
2×SO4; 2×O90;
Assess
X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha
3ipu
 Heteromer
Q13133; Q15788; 		204-445
2×O40; 2×SO4;
Assess
X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha
3ipq
 Heteromer
Q13133; Q15788; 		205-445
2×965; 2×SO4;
Assess
Crystal structure of the LXRalfa-RXRbeta LBD heterodimer
1uhl
 Heteromer
P28702; Q13133; Q15596; 		207-445
1×MEI; 1×444;
Assess

12 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4nqa.1.Bmonomer0.7485-444
2×ZN;73.70
Assess
4nqa.2.Bmonomer0.7486-445
2×ZN; 1×965;73.70
Assess
5uan.1.Bmonomer0.6597-444
1×ZN;34.23
Assess
7wnh.4.Amonomer0.6298-444
1×ZN;29.43
Assess
7wnh.2.Amonomer0.6197-443
2×ZN;29.43
Assess
3dzy.1.Bmonomer0.6195-445
1×ZN;28.65
Assess
4iqr.2.Bmonomer0.5796-444
2×ZN;30.72
Assess
4iqr.2.Amonomer0.5796-444
2×ZN;30.72
Assess
7prw.1.Bmonomer0.5795-446
2×ZN;24.25
Assess
3dzy.1.Amonomer0.5295-430
2×ZN;31.09
Assess
5uan.1.Amonomer0.5297-430
1×ZN;31.49
Assess
4nqa.2.Amonomer0.5197-430
1×ZN;31.49
Assess